↓ Skip to main content

Cochrane Database of Systematic Reviews

Duloxetine for treating painful neuropathy or chronic pain

Overview of attention for article published in this source, October 2009
Altmetric Badge

Mentioned by

1 policy source
1 tweeter
1 Facebook page
1 Wikipedia page


161 Dimensions

Readers on

95 Mendeley
Duloxetine for treating painful neuropathy or chronic pain
Published by
John Wiley & Sons, Ltd, October 2009
DOI 10.1002/14651858.cd007115.pub2
Pubmed ID

Lunn, Michael PT, Hughes, Richard AC, Wiffen, Philip J


Duloxetine is a balanced serotonin and noradrenaline reuptake inhibitor licensed for the treatment of major depressive disorders, urinary stress incontinence and the management of neuropathic pain associated with diabetic peripheral neuropathy. A number of trials have been conducted to investigate the use of duloxetine in neuropathic and nociceptive painful conditions.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
United States 2 2%
Spain 1 1%
Hong Kong 1 1%
Unknown 89 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 17%
Student > Master 15 16%
Student > Bachelor 10 11%
Student > Postgraduate 10 11%
Student > Ph. D. Student 9 9%
Other 16 17%
Unknown 19 20%
Readers by discipline Count As %
Medicine and Dentistry 33 35%
Psychology 11 12%
Nursing and Health Professions 7 7%
Agricultural and Biological Sciences 4 4%
Chemistry 4 4%
Other 13 14%
Unknown 23 24%